Erika Berman Rosenzweig, M.D.
Erika Berman Rosenzweig, M.D., is an internationally prominent physician in her field, with a reputation as an outstanding clinician, teacher, and researcher. An expert in the field of pulmonary hypertension, Dr. Rosenzweig joined New York Medical College as chair and Westchester Medical Center as director of the Department of Pediatrics and as the William Russell McCurdy Physician-in-Chief at WMCHealth’s Maria Fareri Children’s Hospital in 2024. She previously served as vice chair for clinical/translational research in the Department of Pediatrics and director of the Adult and Pediatric Pulmonary Hypertension Comprehensive Care Center at Columbia University Medical Center/NewYork-Presbyterian Hospital.
Education
- M.D., Mount Sinai School of Medicine
- Residency in Pediatrics, Columbia University
- Fellowship in Pediatric Cardiology and Pulmonary Hypertension, Columbia University
- Board-certified in pediatric cardiology and adult congenital heart disease
Research
Dr. Rosenzweig’s research has been widely published and she has served as site principal investigator on more than 50 clinical drug trials, devoting remarkable efforts toward clinical research on the study of novel treatments of pulmonary arterial hypertension, as well as novel approaches to mechanical support for patients with end-stage pulmonary hypertension. She currently serves as director of the Pediatric Pulmonary Hypertension Network of North America, as a Pediatric Task Force advisor for the 2024 World Symposium on pulmonary hypertension, and as immediate past chair of the Pulmonary Vascular Disease Interdisciplinary Network Steering Committee for the International Society for Heart and Lung Transplantation.
Publications
- Mukherjee M, Mathai SC, Jellis C, et. al. "Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease from the PVDOMICS Study." Circulation. Cardiovascular imaging, 17(10), (2024) . pii: e017074. doi: 10.1161/circimaging.124.017074
- Hopper RK, Hansmann G, Hollander SA, et. al. "Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association." Circulation. Heart failure, (), (2024) e000086. doi: 10.1161/HHF.0000000000000086
- Shelburne NJ, Nian H, Beck GJ, et. al. "Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort." CHEST pulmonary, 2(3), (2024) . pii: 100046. doi: 10.1016/j.chpulm.2024.100046
- Nemeh C, Schmoke N, Patten W, et. al. "Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single-institutional experience of outcomes." Pulmonary circulation, 14(4), (2024) e12442. doi: 10.1002/pul2.12442
- Reddy YNV, Frantz RP, Hassoun PM, et. al. "Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension." Journal of the American College of Cardiology, 84(22), (2024) 2196-2210. doi: 10.1016/j.jacc.2024.08.061
- Ivy D, Rosenzweig EB, Abman SH, et. al. "Embracing the challenges of neonatal and paediatric pulmonary hypertension." The European respiratory journal, 64(4), (2024) . doi: 10.1183/13993003.01345-2024
- Gross RS, Thaweethai T, Kleinman LC, et. al. "Characterizing Long COVID in Children and Adolescents." JAMA, 332(14), (2024) 1174-88. doi: 10.1001/jama.2024.12747
Memberships and Affiliations
She has also been an active member of the Pulmonary Hypertension Association (PHA), currently serving as a distinguished faculty advisor to the Scientific Leadership Council. She previously served on the PHA Board of Trustees, as chair of the Scientific Leadership Council, and as editor-in-chief of the medical journal Advances in Pulmonary Hypertension.
